| CVSCX | QDARX | CVSCX / QDARX | |
| Total Expense Ratio | 2.01 | 1.66 | 121% |
| Annual Report Gross Expense Ratio | 2.01 | 1.66 | 121% |
| Fund Existence | 27 years | 12 years | - |
| Gain YTD | 3.522 | 3.747 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 50000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 18.6B | 2.87B | 647% |
| Annual Yield % from dividends | 0.78 | 2.14 | 37% |
| Returns for 1 year | 5.66 | 5.97 | 95% |
| Returns for 3 years | 15.22 | 18.27 | 83% |
| Returns for 5 years | 16.46 | 18.37 | 90% |
| Returns for 10 years | 30.77 | 91.40 | 34% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IDNA | 40.08 | 0.79 | +2.01% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||
| SCHG | 35.32 | 0.22 | +0.63% |
| Schwab US Large-Cap Growth ETF™ | |||
| SPDG | 47.01 | 0.25 | +0.54% |
| State Street SPDR PortS&PSectNetrlDivETF | |||
| AAA | 24.95 | 0.01 | +0.02% |
| Alternative AccessFirstPriorityCLO BdETF | |||
| GIGB | 44.88 | -0.04 | -0.09% |
| Goldman Sachs Acss Invmt Grd Corp Bd ETF | |||